Canadian Cannabis Market: Page 11

Quebec Approves Cannabis Law to Raise Legal Age to 21

The age limit will be raised from 18 to 21 on Jan. 1, 2020, and it will be the highest in Canada.

Choom Appoints Corey Gillon as Chief Executive Officer

The strengthening of Choom's senior management team is a major component of the company's strategic initiative to become a nation-wide cannabis retail organization.

Tantalus Labs Announces Definitive Agreement for Contract Growing Agreement with Zenabis Global Inc. at Langley Greenhouse

The agreement is set to expand the supply chain for Tantalus Labs' exclusive phenotypes, the "Tantalus Range," with the British Columbian agricultural team.

Neptune Achieves a Milestone with Completion of Phase II Expansion

The Sherbrooke facility is set to reach annual run-rate of 200,000 kg by the end of November.

Kiaro Signs Investment and Collaboration Agreement with High Park

The commitment supports the Vancouver-based cannabis brand’s accelerated expansion across Canada.

Cannabis 2.0: Canadian Cannabis Companies Prepare for Legal Edibles, Extracts and Topicals

The additional cannabis products are legal as of Oct. 17, but likely won’t hit store shelves until mid-December.

Emerald Health Therapeutics Announces Update on Pure Sunfarms Supply Agreement

Emerald Health does not agree that it has any liability under the current supply agreement.

Nextleaf Solutions Enters into Agreement to Consolidate Nextleaf Labs

Nextleaf Labs is designed to process more than 270,000 kg of dried cannabis and hemp biomass per year using Nextleaf Solutions' patented intellectual property.

Canopy Growth Completes Previously Announced Acquisition of Beckley Canopy Therapeutics

Canopy has closed the previously announced acquisition of all outstanding shares in the global cannabinoid-based research company Beckley Canopy Therapeutics.

MedMen-PharmaCann Acquisition Falls Apart, New Report Says Vaping-Related Illnesses Similar to Chemical Burns: Week in Review

MedMen and PharmaCann have terminated a $682-million acquisition deal that would have allowed MedMen to purchase PharmaCann in an all-stock transaction.

FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation

The company has appointed former U.S. Congressman Stephen Buyer to the company’s Board of Directors.

Quebec Files Appeal After Court Strikes Down Home Grow Ban

The government is moving forward with a legal challenge after a judge ruled that the province cannot ban its citizens from growing their own adult-use cannabis at home.

Previous Page

Page 11 of 14

Next Page